Radiopharmaceutical evaluation of novel bifunctional chelators and bioconjugates for tumour imaging and therapy
Ad hoc · Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany
Oct 12, 2022
Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany
Listed by exact name; people who share a name appear together, with the affiliation each item gives.
Ad hoc · Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden- Rossendorf (HDZR), Germany
Oct 12, 2022
We use cookies for analytics.